Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents

Open access

Abstract

Mutations in the gene encoding for filaggrin (FLG) are major predisposing factors for atopic dermatitis (AD). Besides genetic predisposition, immunological dysregulations considerably contribute to its pathophysiology. For example, thymic stromal lymphopoietin (TSLP) is highly expressed in lesional atopic skin and significantly contributes to the pathogenesis of AD by activating dendritic cells that then initiate downstream effects on, for example, T cells. However, little is known about the direct interplay between TSLP, filaggrin-deficient skin and other immune cells such as T lymphocytes. In the present study, FLG knockdown skin equivalents, characterised by intrinsically high TSLP levels, were exposed to activated CD4+ T cells. T cell exposure resulted in an inflammatory phenotype of the skin equivalents. Furthermore, a distinct shift from a Th1/Th17 to a Th2/Th22 profile was observed following exposure of T cells to filaggrin-deficient skin equivalents. Interestingly, TSLP directly stimulated T cell migration exclusively in filaggrin-deficient skin equivalents even in the absence of dendritic cells, indicating a hitherto unknown role of TSLP in the pathogenesis of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-00670-2

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Exposure to activated CD4+ T cells induces inflammatory responses in normal (FLG+) and filaggrin-deficient (FLG−) skin equivalents. (a,b) Levels of the pro-inflammatory cytokines IL-6 and IL-8 in FLG+ and FLG− skin equivalents, with and without exposure to activated CD4+ T cells (mean ± SEM, n = 7). (c) Skin surface pH of FLG+ and FLG− skin equivalents before and after exposure to activated CD4+ T cells (mean ± SEM, n = 3). (d) Skin permeability of FLG+ (○) and FLG− (□) skin equivalents without activated CD4+ T cells and FLG+ (○) and FLG− (□) skin equivalents after exposure to activated CD4+ T cells (mean ± SEM, n = 4). *Indicates statistically significant differences between FLG+ skin equivalents (**p ≤ 0.01), +indicates statistically significant differences between FLG− skin equivalents (++ p ≤ 0.01).
Figure 1 Exposure to activated CD4+ T cells induces inflammatory responses in normal (FLG+) and filaggrin-deficient (FLG−) skin equivalents. (a,b) Levels of the pro-inflammatory cytokines IL-6 and IL-8 in FLG+ and FLG− skin equivalents, with and without exposure to activated CD4+ T cells (mean ± SEM, n = 7). (c) Skin surface pH of FLG+ and FLG− skin equivalents before and after exposure to activated CD4+ T cells (mean ± SEM, n = 3). (d) Skin permeability of FLG+ (○) and FLG− (□) skin equivalents without activated CD4+ T cells and FLG+ (○) and FLG− (□) skin equivalents after exposure to activated CD4+ T cells (mean ± SEM, n = 4). *Indicates statistically significant differences between FLG+ skin equivalents (**p ≤ 0.01), +indicates statistically significant differences between FLG− skin equivalents (++ p ≤ 0.01).CC BY · PubMed Central
Figure 2 Exposure of activated CD4+ T cells to the skin equivalents reduces the expression of important skin barrier and tight junction proteins. Western blot and relative protein expression semi-quantified by densitometry, as well as representative immunostaining of normal (FLG+) and filaggrin-deficient (FLG−) skin equivalents alone and after addition of activated CD4+ T cells for (a) filaggrin (FLG, red), (b) involucrin (IVL, green), (c) loricrin (LOR, green), (d) occludin (OCLN, green) and (e) claudin-1 (CLDN-1, red). Counterstained with DAPI (blue), scale bar = 100 μm. *Indicates statistically significant differences between FLG+ skin equivalents (*p ≤ 0.05), +indicates statistically significant differences between FLG− skin equivalents (+ p ≤ 0.05). (Mean ± SEM; n = 4).
Figure 2 Exposure of activated CD4+ T cells to the skin equivalents reduces the expression of important skin barrier and tight junction proteins. Western blot and relative protein expression semi-quantified by densitometry, as well as representative immunostaining of normal (FLG+) and filaggrin-deficient (FLG−) skin equivalents alone and after addition of activated CD4+ T cells for (a) filaggrin (FLG, red), (b) involucrin (IVL, green), (c) loricrin (LOR, green), (d) occludin (OCLN, green) and (e) claudin-1 (CLDN-1, red). Counterstained with DAPI (blue), scale bar = 100 μm. *Indicates statistically significant differences between FLG+ skin equivalents (*p ≤ 0.05), +indicates statistically significant differences between FLG− skin equivalents (+ p ≤ 0.05). (Mean ± SEM; n = 4).CC BY · PubMed Central
Figure 3 The presence of CD4+ T cells disorders stratum corneum (SC) barrier lipids of normal (FLG+), but not filaggrin-deficient (FLG−), skin equivalents. (a,b) Infrared spectroscopy of isolated SC (spectra and wavenumbers of methylene asymmetric stretching vibration). (Mean ± SEM; n = 4). (c–e) High-performance thin layer chromatography analysis of SC lipids (free fatty acids, ceramide subclasses and glucosylceramides) of FLG+ and FLG− skin equivalents with or without exposure to activated CD4+ T cells (mean ± SEM; n = 4). *Indicates statistically significant differences between FLG+ skin equivalents (*p ≤ 0.05, **p ≤ 0.01).
Figure 3 The presence of CD4+ T cells disorders stratum corneum (SC) barrier lipids of normal (FLG+), but not filaggrin-deficient (FLG−), skin equivalents. (a,b) Infrared spectroscopy of isolated SC (spectra and wavenumbers of methylene asymmetric stretching vibration). (Mean ± SEM; n = 4). (c–e) High-performance thin layer chromatography analysis of SC lipids (free fatty acids, ceramide subclasses and glucosylceramides) of FLG+ and FLG− skin equivalents with or without exposure to activated CD4+ T cells (mean ± SEM; n = 4). *Indicates statistically significant differences between FLG+ skin equivalents (*p ≤ 0.05, **p ≤ 0.01).CC BY · PubMed Central
Figure 4 CD4+ T cell migration occurs exclusively in filaggrin-deficient (FLG−) skin equivalents. (a) Representative light microscopy picture of a FLG− skin equivalent containing migrated T cells attached to magnetic beads (arrows). (b) Corresponding immunostaining against CD4+ T cells (red), counterstained with DAPI (blue), scale bar = 100 µm. (c) Immunostaining against non-activated CD4+ T cells (red, arrows) in FLG− skin equivalents, counterstained with DAPI (blue). Representative light microscopy picture of (d) a normal (FLG+) skin equivalent and (e) FLG− skin equivalents generated from keratinocytes transfected with siRNA negative control after exposure to activated T cells (arrows, attached to magnetic beads; scale bar = 100 µm, SC = stratum corneum, VE = viable epidermis, D = dermis).
Figure 4 CD4+ T cell migration occurs exclusively in filaggrin-deficient (FLG−) skin equivalents. (a) Representative light microscopy picture of a FLG− skin equivalent containing migrated T cells attached to magnetic beads (arrows). (b) Corresponding immunostaining against CD4+ T cells (red), counterstained with DAPI (blue), scale bar = 100 µm. (c) Immunostaining against non-activated CD4+ T cells (red, arrows) in FLG− skin equivalents, counterstained with DAPI (blue). Representative light microscopy picture of (d) a normal (FLG+) skin equivalent and (e) FLG− skin equivalents generated from keratinocytes transfected with siRNA negative control after exposure to activated T cells (arrows, attached to magnetic beads; scale bar = 100 µm, SC = stratum corneum, VE = viable epidermis, D = dermis).CC BY · PubMed Central
Figure 5 TSLP directly stimulates T cell migration in filaggrin-deficient (FLG−) skin equivalents. (a) Western blot and relative protein expression of TSLP in normal (FLG+) and FLG− skin equivalents before and after exposure to activated CD4+ T cells (mean ± SEM; n = 4), *indicates statistical significance over FLG+ skin equivalents (*p ≤ 0.05, **p ≤ 0.01). (b) Representative immunostains against TSLP (red) in FLG+ and FLG− skin equivalents (scale bar = 100 μm). (c) Representative light microscopy pictures of FLG− skin equivalents supplemented with activated CD4+ T cells (control) and with TSLPr antibody pre-incubated T cells (+TSLPr), scale bar = 100 µm. (d) Dermis equivalents, with and without topical application of 50 ng/ml TSLP, prior to T cell exposure (scale bar = 100 µm). (e) Representative dot plots from the flow cytometric transwell migration assay with non-activated and activated CD4+ T cells, incubated for 48 h with medium only (negative control), 30 ng/ml SDF-1α (positive control), and 50 ng/ml TSLP with and without pre-incubation with TSLPr antibody.
Figure 5 TSLP directly stimulates T cell migration in filaggrin-deficient (FLG−) skin equivalents. (a) Western blot and relative protein expression of TSLP in normal (FLG+) and FLG− skin equivalents before and after exposure to activated CD4+ T cells (mean ± SEM; n = 4), *indicates statistical significance over FLG+ skin equivalents (*p ≤ 0.05, **p ≤ 0.01). (b) Representative immunostains against TSLP (red) in FLG+ and FLG− skin equivalents (scale bar = 100 μm). (c) Representative light microscopy pictures of FLG− skin equivalents supplemented with activated CD4+ T cells (control) and with TSLPr antibody pre-incubated T cells (+TSLPr), scale bar = 100 µm. (d) Dermis equivalents, with and without topical application of 50 ng/ml TSLP, prior to T cell exposure (scale bar = 100 µm). (e) Representative dot plots from the flow cytometric transwell migration assay with non-activated and activated CD4+ T cells, incubated for 48 h with medium only (negative control), 30 ng/ml SDF-1α (positive control), and 50 ng/ml TSLP with and without pre-incubation with TSLPr antibody.CC BY · PubMed Central
Figure 6 Impact of TSLP on the differentiation profile of activated CD4+ T cells. (a) Levels of IFN-γ, TNF-α, IL-22, IL-17A and IL-13 produced by activated CD4+ T cells (mean ± SEM; n = 3–5). (b–f) Respectively, release of, IFN-γ, TNF-α, IL-17A, IL-13 and IL-22 from activated CD4+ T cells alone (white bar) and after addition to FLG− skin equivalents (grey bar), relative to 106 CD4+ T cells (mean ± SEM; n = 3–5; *p ≤ 0.05, **p ≤ 0.01). (g–j) Respectively, relative mRNA expression of T cell master regulators TBX21 (Th1), GATA3 (Th2), RORC (Th17) and AHR (Th22).
Figure 6 Impact of TSLP on the differentiation profile of activated CD4+ T cells. (a) Levels of IFN-γ, TNF-α, IL-22, IL-17A and IL-13 produced by activated CD4+ T cells (mean ± SEM; n = 3–5). (b–f) Respectively, release of, IFN-γ, TNF-α, IL-17A, IL-13 and IL-22 from activated CD4+ T cells alone (white bar) and after addition to FLG− skin equivalents (grey bar), relative to 106 CD4+ T cells (mean ± SEM; n = 3–5; *p ≤ 0.05, **p ≤ 0.01). (g–j) Respectively, relative mRNA expression of T cell master regulators TBX21 (Th1), GATA3 (Th2), RORC (Th17) and AHR (Th22).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 82

Metadata

Authors
Wallmeyer, L., Dietert, K., Sochorová, M., Gruber, A. D., Kleuser, B., Vávrová, K., & Hedtrich, S.
Affiliations
  • Freie Universität Berlin (DE)
  • Charles University (CZ)
  • University of Potsdam (DE)
Corresponding author
Hedtrich, Sarah
Venue
Scientific Reports
Published
2017-04-04
Volume
7
Issue
1
Pages
774-774
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2605302240
Cited by
82
References
75
Citations by year
2026: 7 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 13 · 2020: 15 · 2019: 4 · 2018: 5 · 2017: 5
FWCI
9.01
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • publish.UP (University of Potsdam) (submittedVersion)
  • Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
  • Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
Funders
Grantová Agentura České Republiky (GC16-25687J)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
thymic stromal lymphopoietin, filaggrin, atopic dermatitis, T cell migration, skin equivalents, CD4+ T cells, dendritic cells, skin inflammation
MeSH terms
Filaggrin Proteins, Thymic Stromal Lymphopoietin, Cell Movement, Dendritic Cells, Humans, Intermediate Filament Proteins, Lymphocyte Activation, Skin, CD4-Positive T-Lymphocytes, Gene Expression, T-Lymphocyte Subsets, Cytokines, Th1 Cells, Th2 Cells, Lipid Metabolism, Th17 Cells, Tight Junction Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents. https://app.cochat.ai/papers/10.1038/s41598-017-00670-2
The paper
Wallmeyer, L., Dietert, K., Sochorová, M., Gruber, A. D., Kleuser, B., Vávrová, K., & Hedtrich, S. (2017). TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents. Scientific Reports. https://doi.org/10.1038/s41598-017-00670-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.